Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305430200 on September 17, 2003

J. Biol. Chem., Vol. 278, Issue 47, 47340-47349, November 21, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/47/47340    most recent
M305430200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhi, H.
Right arrow Articles by Jin, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhi, H.
Right arrow Articles by Jin, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Fis Stabilizes the Interaction between RNA Polymerase and the Ribosomal Promoter rrnB P1, Leading to Transcriptional Activation*

Huijun Zhi{ddagger}, Xiangdong Wang{ddagger}§, Julio E. Cabrera, Reid C. Johnson¶, and Ding Jun Jin||

From the Laboratory of Molecular Biology, NCI, National Institutes of Health, Bethesda, Maryland 20892 and the Department of Biological Chemistry, David Geffen School of Medicine at UCLA, UCLA, Los Angeles, California 90095-1737

Received for publication, May 23, 2003 , and in revised form, September 12, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
It has been shown that Fis activates transcription of the ribosomal promoter rrnB P1; however, the mechanism by which Fis activates rrnB P1 transcription is not fully understood. Paradoxically, although Fis activates transcription of rrnB P1 in vitro, transcription from the promoter containing Fis sites (as measured from rrnB P1-lacZ fusions) is not reduced in a fis null mutant strain. In this study, we further investigated the mechanism by which Fis activates transcription of the rrnB P1 promoter and the role of Fis in rRNA synthesis and cell growth in Escherichia coli. Like all other stringent promoters investigated so far, open complex of rrnB P1 has been shown to be intrinsically unstable, making open complex stability a potential regulatory step in transcription of this class of promoters. Our results show that Fis acts at this regulatory step by stabilizing the interaction between RNA polymerase and rrnB P1 in the absence of NTPs. Mutational analysis of the Fis protein demonstrates that there is a complete correlation between Fis-mediated transcriptional activation of rrnB P1 and Fis-mediated stabilization of preinitiation complexes of the promoter. Thus, our study indicates that Fis-mediated stabilization of RNA polymerase-rrnB P1 preinitiation complexes, presumably at the open complex step, contributes prominently to transcriptional activation. Furthermore, our in vivo results show that rRNA synthesis from the P1 promoters of several rRNA operons are reduced 2-fold in a fis null mutant compared with the wild type strain, indicating that Fis plays an important role in the establishment of robust rRNA synthesis when E. coli cells are emerging from a growth-arrested phase to a rapid growth phase. Thus, our results resolve an apparent paradox of the role of Fis in vitro and in vivo in the field.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In nutrient-rich media, most RNA polymerase (RNAP)1 molecules inside rapidly dividing Escherichia coli cells are engaged in transcription of a small set of genes in the genome, whose products, such as rRNA and tRNA, are primarily involved in translation (1, 2). However, when cells are shifted from nutrient-rich to nutrient starvation conditions, the cellular transcription machinery is reprogrammed to respond to the environmental cue, a process called the stringent response (for a review, see Ref. 3). One of the most dramatic effects of the stringent response is to "turn off" the expression of those genes that are most active in nutrient-rich conditions; thus, those genes are stringently regulated, and the promoters from these genes are called stringent promoters.

We and others have shown that one unique feature shared by all stringent promoters tested is that the interactions between RNAP and stringent promoters are intrinsically unstable (4, 5). Preinitiation complexes of stringent promoters are unstable because the steps prior to the first phosphodiester bond formation are reversible, with the intermediate closed and open complexes being in rapid equilibrium. The intrinsically unstable preinitiation complexes of stringent promoters probably represent the isomerized open complex that is competent for RNA synthesis. Formation of the first phosphodiester bond results in an initially transcribing complex, which becomes very stable. Contrary to stringent promoters, open preinitiation complexes at nonstringent promoters are generally very stable, and backward reactions to closed complexes are negligible (6). Moreover, we found that several rifampicin-resistant RNAPs, purified from the rpoB mutants that exhibited the stringent response phenotype even in rich media (thus, they are called stringent RNAPs), further destabilize preinitiation complexes with the stringent promoters tested when compared with wild type RNAP (5, 7). As expected, all of these rpoB mutations confer a slow growth phenotype (~50% of growth rate of wild type cells in rich media), and total RNA synthesis is reduced in these stringent RNAP mutants compared with wild type strain (8, 9). Other RNAP mutants that exhibited partial stringent response phenotypes have also been studied with similar results (10). Taken together, we and others proposed that a potential regulatory step in transcription of stringent promoters is at the interaction between RNAP and the promoter, presumably at the stability of the open complex, and hence factors that act at this regulatory step would modulate transcription of stringent promoters and the stringent (nutrient starvation) response (5, 10).

The rrnB P1 promoter is one of the best studied stringent promoters in E. coli (for a review, see Ref. 11). Because the sequences of the promoters/regulatory regions are conserved in all of the seven rRNA operons (12), it is likely that the rrnB P1 is representative of the P1 promoters of all rRNA operons. There are multiple elements (both cis and trans) that contribute to the strength and the regulation of rrnB P1 (1319). Among them, Fis functions as a trans-activator of rrnB P1 transcription (15).

Fis is a nucleoid-associated and site-specific DNA-binding protein that plays an important role in gene expression and site-specific DNA recombination (20, 21). The expression of fis is subject to growth phase regulation, with its peak expression around the first doubling time after overnight cultures are diluted into a fresh rich medium; thus, the cellular level of Fis is highest at the very early log phase and lowest at the stationary phase (22, 23). Fis exists as a dimer in solution, and its crystal structure is known (2426). Mutational analyses indicate that the domains in Fis that are important for its different functions are distinct (27, 28). For example, the "activation patch" of Fis, responsible for transcriptional activation of several promoters including rrnB P1, is located in residues Gln68, Arg71, Gly72, and Gln74, within and flanking the {beta}-turn connecting helices B and C adjacent to the C-terminal helix-turnhelix DNA binding motif (2932), whereas residues near the N terminus (Val16, Asp20, and Val22) are critical for the DNA inversion activity (2628). Although there are three Fis binding sites in rrnB P1, most activation by Fis is attributable to site I of the promoter, where Fis interacts with the C-terminal domain of the {alpha} subunit of RNAP (15, 30, 32, 33). However, some other rrn promoters, such as rrnA P1, require all three Fis binding sites for effective activation (34, 35).

The mechanism underlying the activation of rrnB P1 by Fis has not been fully elucidated, although much is known about the interactions between RNAP and Fis at the ribosomal promoter (30, 36). Paradoxically, although Fis activates transcription of rrnB P1 in vitro, transcription from the promoter containing Fis sites (as measured from rrnB P1-lacZ fusions) is not reduced in a fis null mutant strain (15, 37). Moreover, the effects of the fis mutations on cell growth are inconsistent and often negligible compared with wild type cells (15, 37, 38). To account for the apparent contradictions between the in vitro and in vivo results by Fis, a feedback mechanism was proposed for the regulation of rrnB P1 (15, 37).

In this study, we investigated the mode of action by Fis on the transcriptional activation of rrnB P1. We demonstrated that Fis stabilizes the interaction between RNAP and the rrnB P1 promoter, probably at the step of open preinitiation complexes in the absence of NTPs, thus leading to enhanced transcription. Furthermore, our results demonstrate that Fis plays an important role in establishing robust rRNA synthesis when cells emerge from an arrested state in stationary phase to a rapid growing state in early log phase.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Chemicals and Reagents—Nucleotides, [{alpha}-32P]UTP, and [{gamma}-32P]ATP were purchased from Amersham Biosciences. Glutamic acid, potassium glutamate, and heparin were from Sigma. Magnesium glutamate was from Fluka. Plasmid pRLG1617 containing the rrnB P1 promoter (-88 to +1) and rrnB T1T2 terminators was kindly provided by Wilma Ross and Richard Gourse (University of Wisconsin, Madison, WI) and described (5). Plasmid pDJ4335, a derivative of pRLG1617, contains a mutant rrnB P1 promoter in which all the G/C in the discriminator sequence upstream of +1 was changed into A/T by PCR-mediated mutagenesis. The DNA sequences of the two primers for the amplification of the rrnB P1 DNA (-88 to +1) and introduction of the discriminator mutations were 5'-CGGAATTCAGGCTGATTTGGTTGAAT (upper strand) and 5'-CCCAAGCTTAATTAATAATTATAGGGAGTTAT (lower strand). The lower strand primer has mutations in the discriminator region (underlined in the above sequences). PCR was performed using pRLG1617 DNA as template. The PCR product was digested with EcoRI and HindIII and then inserted into the EcoRI-HindIII sites of pRLG1617 to replace the wild type rrnB P1 sequence. The plasmid supercoiled DNA was purified with a Qiagen plasmid purification kit. RNAPs were purified as described (39). The stringent RNAPs (RpoB114, RpoB3770, and RpoB3449) were described (5). The wild type and mutant Fis proteins used in this study were overproduced and purified as described elsewhere (30, 32).

Bacterial Strains and Bacteriological Techniques—Basic bacterial techniques were used as described previously (40). The E. coli strains used were K12 MG1655 (laboratory collection from Carol Gross, University of California, San Francisco) and its derivatives. The fis null mutant strains were constructed by phage P1 transduction with a lysate made from strain RLG1351 (MG1655 {Delta} lacX74/{lambda} rrnB P1 fis::kan (5)), and Kanr transductants were selected.

In Vitro Transcription Assays—Reactions were performed at room temperature (~23 °C) essentially as described previously (5). The transcription mixtures with 0.1 mM dithiothreitol, 0.1 mg/ml acetylated bovine serum albumin, and 5% glycerol containing either KCl/NaCl or potassium glutamate. The former contained 40 mM Tris-HCl (pH 8.0), 10 mM MgCl2, and the indicated concentrations of KCl/NaCl. The latter contained 20 mM Tris-glutamate (pH 8.0), 10 mM magnesium glutamate, and 200 mM or indicated concentrations of potassium glutamate. The concentrations of supercoiled plasmid and RNAPs were 4–5 and 2–4 nM, respectively. Each of the Fis proteins (wild type and the mutants) was titrated, and the concentration (usually ~150 nM) that gave maximal activation of the rrnB P1 effect was used in the reactions as indicated. The reaction mixtures were preincubated for 15 min, and reactions were initiated by the addition of NTPs (0.2 mM ATP, CTP, and GTP and 0.02 mM UTP including 5 µCi of [{alpha}-32P]UTP). When indicated, heparin (10 µg/ml for KCl and 100 µg/ml for potassium glutamate) was added with NTPs at the same time. After 10 min, reactions were terminated by the addition of an equal volume of stop solution (95% formamide, 20 mM EDTA 0.1% bromphenol, and 0.1% xylene cyanol) and analyzed on a 6% sequencing gel (National Diagnostics). The signals were visualized and quantified using PhosphorImager equipment (STORM 680; Amersham Biosciences).

Determination of the Kinetics of Inactivation of Preinitiation Complexes at rrnB P1 by the DNA Competitor Heparin—Conditions were the same as described above for in vitro transcription with the following modifications. After preincubation of RNAP, Fis protein as indicated, and DNA template for 15 min, heparin was added into reactions at time 0. Aliquots were taken and mixed with NTPs at specified time intervals after the addition of inhibitor. The transcription reactions were allowed to continue for another 10 min before being terminated and analyzed as described above. The data were analyzed, and half-lives were calculated. To ensure consistency in the measurement of half-lives of preinitiation complexes in the presence of Fis mutant proteins, we always included wild type Fis in the same set of experiments.

RNA Extraction—Overnight cultures were diluted 20-fold in fresh prewarmed LB medium and grown at 37 °C. Total RNA was extracted from 3 ml of cell cultures after dilution at the indicated time intervals by a hot phenol procedure (41). The RNA samples were further purified by use of RNeasy Mini Kit (Qiagen) and eluted from the RNeasy column in 30 µl of diethylpyrocarbonate-treated water according to the manufacturer's instructions. The RNA concentration was determined by measuring the optical density at 260 nm.

Primer Extension Analysis—Primer NSL166 (5'-GGGTGTGCATAATACGCC-3') was used in extension reactions to detect the RNA synthesized exclusively from the P1 promoters of four E. coli rRNA operons (rrnB, rrnA, rrnC, and rrnG). Primer NSL 939 (5'-ACGAGATAACACGGTTAAATCC-3') was used to determine the RNA synthesized from the ompA promoters, P1 and P2. The expected extension products were 119 bases for rrn P1 and 93 and 89 bases for ompA P1 and P2, respectively. About 1 µg of total RNA and 2 pmol of each 32P-labeled primer were used in the extension reactions, using the AMV reverse transcriptase primer extension system (Promega) at 42 °C in accordance with the manufacturer's protocol. After primer extension, the samples were loaded on 6% sequencing gel and analyzed by the PhosphorImager. The length of the transcripts was determined using corresponding sequencing reactions as references.

Measurement of the Stability of the Leader rRNAs Initiated at the rrn P1 Promoters in Vivo—The overnight cultures of both MG1655 and MG1655 fis (DJ2592) were diluted 20-fold in fresh prewarmed LB medium and grown at 37 °C. After 30 min of incubation, rifampicin was added to the cells to a final concentration of 250 µg/ml, and samples were removed for RNA extraction at various intervals (0, 20, 40, 60, 120, and 240 s). For time 0, the RNA was extracted immediately before the addition of rifampicin. The RNAs were extracted, processed, and analyzed by primer extension for the leader rRNAs initiated at the rrn P1 promoter as described above. The amount of RNA samples used for primer extension assay was 1 µg for MG1655 and 2.5 µg for MG1655 fis. The products of primer extension were resolved on 6% sequencing gel and analyzed by phosphorimaging.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Stringent RNAPs That Further Destabilize the Intrinsically Unstable Preinitiation Complexes at rrnB P1 Display Enhanced Activation by Fis—To understand the mechanism by which Fis activates transcription of rrnB P1, we initially analyzed the effect of Fis on the transcription of the promoter with the stringent RNAPs described above (Fig. 1). Although Fis activates transcription of rrnB P1 by wild type RNAP greatly only at high concentrations of KCl or NaCl (150 mM) in vitro (15), the experiments were performed with low salt (30 mM KCl), because the syntheses of rrnB P1 by the stringent RNAPs were extremely sensitive to high salt (5). Previously, we showed that whereas these stringent RNAPs (RpoB114, RpoB3449, and RpoB3370) are defective in transcription of stringent promoters, they are proficient in transcription of RNAI (as a control for nonstringent promoter of plasmid origin) (5). Since Fis does not affect RNAI synthesis, the effects of these stringent RNAPs on the transcription of rrnB P1 can be quantified as the ratios of the transcripts of rrnB P1 over RNAI.



View larger version (47K):
[in this window]
[in a new window]
 
FIG. 1.
Effect of Fis on the transcription of rrnB P1 by wild type (WT) and stringent mutant RNAPs in vitro. In vitro transcription assays were performed with 30 mM KCl in the absence (A and B) or the presence of heparin (C and D) as described under "Experimental Procedures." A and C show autoradiograms of representative in vitro transcription assays. The transcripts from rrnB P1 (~170 nucleotides) and RNAI (~110 nucleotides) are indicated. The amounts of rrnB P1, normalized to RNAI, made by different RNAPs in the absence of heparin (B) or in the presence of heparin (D), were plotted. The results presented are the average of three independent experiments, and the numbers in parenthesis represent the -fold activation by Fis.

 
As shown in Fig. 1, A and B, these mutant RNAPs were defective in the synthesis of rrnB P1 compared with wild type RNAP even at 30 mM KCl. Among them, RpoB3449 is the least defective (~3.7-fold reduction), and RpoB114 is the most defective (~15-fold reduction). At this low salt concentration, Fisactivated transcription of rrnB P1 by wild type RNAP only marginally (1.4-fold). However, Fis activated transcription of rrnB P1 by the stringent RNAPs 2–3-fold.

In the presence of DNA competitor heparin (Fig. 1, C and D), which was added at the same time as NTPs to trap either dissociated or loosely DNA-bound RNAP (42), transcription of rrnB P1 by wild type RNAP was reduced only ~10% compared with that in the absence of heparin (compare lane 1 in Fig. 1C with lane 1 in Fig. 1A), indicating that the preinitiation complexes were relatively stable at 30 mM KCl. Under this condition, Fis activated the transcription only marginally (1.6-fold). However, heparin exacerbated the defects of the stringent RNAPs in transcription of rrnB P1, resulting in a 2–3-fold reduction in transcripts compared with the amount obtained in the absence of the DNA competitor (compare lanes 3, 5, and 7 in Fig. 1A with lanes 3, 5, and 7 in Fig. 1C), consistent with the fact that the preinitiation complexes formed with these mutant RNAPs are significantly more unstable than wild type RNAP. Moreover, the Fis-mediated transcriptional activation of rrnB P1 by the stringent RNAPs was significantly increased in the presence of heparin, ranging from 4- to 6-fold. Note that these stringent RNAPs were still defective in transcription of rrnB P1 compared with wild type RNAP in the presence of Fis.

It has been shown that these stringent RNAPs further destabilize the preinitiation complexes at rrnB P1 compared with wild type RNAP (5). The fact that Fis activated transcription from rrnB P1 by the stringent RNAPs to a greater extent than by wild type RNAP under the conditions used indicates that Fis manifests a greater effect on the relatively unstable initiation complexes. Thus, our results suggest that Fis stabilizes metastable preinitiation complexes of the rrnB P1 promoter, leading to increased transcription.

Fis Stabilizes the Interaction between RNAP and the rrnB P1 Promoter—We decided to determine the effect of Fis on the stability of RNAP-rrnB P1 preinitiation complexes directly. First, we found the conditions under which the half-lives of RNAP-rrnB P1 complexes could be measured experimentally upon challenge with a DNA competitor. Whereas Fis activated transcription of rrnB P1 by wild type RNAP to different extents in the absence of heparin with 30–150 mM KCl or NaCl, very little rrnB P1 transcription occurred in the presence of heparin and salt concentrations above 50 mM even with Fis (data not shown). With potassium glutamate, which is the major intracellular salt in E. coli (43), Fis activates transcription of rrnB P1 from 200 to 500 mM either in the absence or presence of heparin (Fig. 2). Thus, we initially measured the half-life of RNAP-rrnB P1 complexes both at 40 mM KCl and 200 mM potassium glutamate.



View larger version (38K):
[in this window]
[in a new window]
 
FIG. 2.
Effect of Fis on the transcription of rrnB P1 with different concentrations of potassium glutamate (K-Glu). In vitro transcriptions were carried out with wild type RNAP in the absence and presence of heparin as described under "Experimental Procedures." The concentrations of potassium glutamate are indicated.

 
At 40 mM KCl in the absence of Fis, only a very small amount of rrnB P1 transcripts were synthesized by the wild type RNAP after a 15-s incubation with heparin, indicating that only a few complexes competent for initiation remained (Fig. 3A). Although the fast decay of the preinitiation complexes prevented us from obtaining an accurate value of the half-life, it was estimated to be much less than 15 s. However, in the presence of Fis, the preinitiation complexes became relatively resistant to heparin challenge (Fig. 3A), and the half-life of the RNAP-rrnB P1 complexes increased to about 30 s (Fig. 3B).



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 3.
Effect of Fis on the stability of preinitiation complexes of rrnB P1 with wild type RNAP in the presence of different salts. The experiment was performed as described under "Experimental Procedures." The transcription reactions in which heparin was added with NTPs at the same time are indicated as 0. A, autoradiogram of a representative in vitro transcription assay in 40 mM KCl. B, the transcription activities of rrnB P1 and RNAI were plotted as a function of time (after the addition of heparin) with 40 mM KCl. C, autoradiogram of a representative in vitro transcription assay with 200 mM potassium glutamate. D, the transcription activities of rrnB P1 and RNAI are plotted as a function of time (after the addition of heparin) with 200 mM potassium glutamate.

 
Similarly, Fis also increased the half-life of wild type RNAP-rrnB P1 preinitiation complexes when 200 mM potassium glutamate was used (Fig. 3, C and D). With potassium glutamate, the half-life of the RNAP-rrnB P1 complexes in the absence of Fis was about 7 min, whereas in the presence of Fis, the half-life of the RNAP-rrnB P1 complexes increased to about 16 min. With either salt, Fis had no effect on the stability of preinitiation complexes at the RNAI promoter under the conditions used.

We also determined the effect of Fis on the stability of RNAP-rrnB P1 preinitiation complexes with one of the least defective mutant RNAPs: RpoB3449. At 40 mM KCl, even in the presence of Fis, the interaction between RpoB3449 and rrnB P1 was too weak to measure the half-life of the RNAP-rrnB P1 complexes (data not shown). At 200 mM potassium glutamate (Fig. 4), without Fis, RpoB3449 made a very small amount of the rrnB P1 transcripts when challenged with heparin, indicating that the RpoB3449-rrnB P1 preinitiation complexes were extremely unstable; the half-life of the complexes was estimated to be much less than 15 s. However, with Fis, RpoB3449 was able to make a noticeable amount of rrnB P1 transcripts in the presence of heparin, and the half-life of the complexes increased to ~3.5 min. It should be noted that although Fis exhibited a more dramatic effect on stabilizing the preinitiation complexes at rrnB P1 with the mutant RNAP than with the wild type enzyme (which is consistent with the in vitro transcription data (Fig. 1) where Fis activated transcription of rrnB P1 by the stringent RNAP to a greater extent than that by wild type RNAP), the overall stability of the rrnB P1 preinitiation complexes with the stringent RNAP in the presence of Fis was still low compared with that with wild type RNAP.



View larger version (31K):
[in this window]
[in a new window]
 
FIG. 4.
Effect of Fis on stability of preinitiation complexes of rrnB P1 with the mutant RNAP, RpoB3449. The experiment was performed with 200 mM potassium glutamate as described under "Experimental Procedures." The transcription reactions without heparin addition are indicated with a minus sign. A, autoradiogram of a representative in vitro transcription assay. B, the transcription activities of rrnB P1 and RNAI are plotted as a function of time (after the addition of heparin).

 
It has been shown that a G/C-rich region called a discriminator sequence (44) contributes to the instability of preinitiation complexes at several stringent promoters (4547). To determine whether Fis overcomes the negative effect of the discriminator sequence on the initiation complexes of rrnB P1, we constructed a mutant rrnB P1 promoter in which the discriminator sequence was mutated and studied the effect of Fis on the transcription of the mutant promoter (Fig. 5). Compared with the wild type rrnB P1 promoter, the mutant promoter had high activity by both wild type RNAP and the stringent RNAP RpoB3449 in the absence of Fis. Moreover, Fis did not manifest transcriptional activation of the mutant promoter by either wild type or the stringent RNAP. As expected, the preinitiation complexes of the mutant rrnB P1 promoter were stable with a half-life of about 135 min either with or without Fis (data not shown). Our results indicate that Fis, the stringent RNAP, and the discriminator sequence of rrnB P1 affect the same step, which is likely to be a form of the open complex, but in opposite directions to modulate transcription at stringent promoters.



View larger version (43K):
[in this window]
[in a new window]
 
FIG. 5.
Effect of Fis on the transcription of the rrnB P1 discriminator (Dis) mutant promoter by wild type (WT) and stringent mutant RNAP RpoB3449 in vitro. The Dis mutant promoter replaced the G/C-rich GCGCCACC discriminator sequences with A/T-rich TATTAATT sequences as described under "Experimental Procedures." The in vitro transcription reactions were carried out at 200 mM potassium glutamate with wild type (A) and the mutant RpoB3449 RNAP (B) in the presence of 100 µg/ml heparin. The upper panels are autoradiograms of in vitro transcription assays, and the lower panels are the quantifications. The numbers in parentheses represent the -fold activation by Fis.

 
Mutant Fis Proteins Defective in Activating Transcription of rrnB P1 Are Impaired in Their Ability to Stabilize RNAP-rrnB P1 Complexes—The above results indicate that Fis-mediated transcriptional activation of rrnB P1 is the consequence of Fis-mediated stabilization of the preinitiation complexes. To provide further support for this argument, we took advantage of mutational analysis of Fis. Fis mutants that are defective in transcriptional activation at the rrnB P1 promoter and other functions have been described (29, 30, 32). We hypothesized that mutant Fis proteins defective in activating transcription of rrnB P1 would also be impaired for stabilization of RNAP-rrnB P1 complexes, whereas complexes formed with Fis proteins that are defective in other functions would be stabilized. To test this model, we used Fis mutant proteins that altered amino acid residues at the "activation patch" (Gln68, Arg71, and Gly72) important for transcriptional activation of rrnB P1 (30, 32). Also, as a control, we used a mutant Fis protein that altered residue Asp20, whose mutation is not located in the putative interface between Fis and RNAP but is important for Hincatalyzed site-specific inversion (26, 27).

First, we determined the effects of different Fis proteins on transcriptional activation of rrnB P1 in the presence of 200 mM potassium glutamate (Fig. 6, A and B). Wild type Fis stimulated the synthesis of rrnB P1 about 4-fold when compared with levels generated in the absence of Fis under the conditions used. Two Fis mutant proteins, D20K and R71Y, behaved similarly to the wild type Fis protein. Two other Fis mutant proteins, Q68A and R71K, were partially defective in stimulating transcription of rrnB P1 and activated transcription of rrnB P1 only about 2.6- and 1.5-fold, respectively. The other three Fis mutant proteins, R71A, R71Q, and G72A, had minimal activity (<30% of wild type Fis activity) in stimulating transcription of rrnB P1. Similar results were obtained when 150 mM NaCl was used in reactions (data not shown).



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 6.
Effects of various mutant Fis proteins on the transcriptional activation of rrnB P1 and on the stability of preinitiation complexes at the promoter. A and B, effects of different mutant Fis proteins on the transcription of rrnB P1 by wild type RNAP (WT). The in vitro transcriptions were performed with 200 mM potassium glutamate in the presence of heparin as described under "Experimental Procedures." A, an autoradiograph of a representative in vitro transcription gel. B, plot of the relative amount of rrnB P1 transcripts (expressed as the ratio of rrnB P1/RNAI). The data represent an average of three individual experiments. C, effect of different mutant Fis proteins on the stability of preinitiation complexes at rrnB P1. The experiments were carried out with wild type RNAP and various Fis proteins in the presence of 200 mM potassium glutamate as described in the legend to Fig. 3. The half-lives of the preinitiation complexes in the absence or presence of different Fis proteins were analyzed and calculated as described under "Experimental Procedures." The data represent an average of at least two individual experiments for each mutant Fis protein.

 
Second, we analyzed the effects of these mutant Fis proteins on the stability of preinitiation complexes at rrnB P1 (Fig. 6C). As expected from our model, there is a complete correlation between the ability of a Fis protein to activate transcription of rrnB P1 and its ability to stabilize RNAP-rrnB P1 complexes. For example, the two mutant Fis proteins (D20K and R71Y) that were proficient for transcriptional activation behaved exactly like wild type Fis protein in stabilizing the RNAP-rrnB P1 complexes, with a value for the half-life of the complexes estimated to be 18 min. The three Fis mutant proteins (R71A, R71Q, and G72A) that exerted minimal transcriptional activation activity of rrnB P1 also had only a minimal effect on the stability of RNAP-rrnB P1 complexes in initiation. The value of the half-life of RNAP-rrnB P1 complexes in the presence of these Fis mutant proteins was about 8–9 min, a value very similar to that obtained in the absence of Fis. The other two Fis mutant proteins (Q68A and R71K) that only partially activated transcription of rrnB P1 also partially retained their abilities to stabilize RNAP-rrnB P1 complexes, with half-life values of 13 and 11 min, respectively. The complete agreement of the behaviors of these mutant Fis proteins in the two assays strongly suggests that the two activities of Fis in transcription of the ribosomal promoter (stabilization of the preinitiation complexes and activation of the transcription) are intimately related.

Fis-mediated Transcriptional Activation of Ribosomal RNA Synthesis Is Manifested during Early Log Phase in Vivo—The in vitro studies described above would predict that Fis plays an important role in regulation of the synthesis of rRNA operons inside the cell (all seven rRNAP operons in E. coli have similar sequences in the P1 promoter/regulatory regions) under some physiological conditions. However, a fis null mutation has no or minimal effect on the expression of rrnB P1 containing Fis sites in vivo (15, 37, 48). This lack of the in vivo phenotype of the fis mutant could be due to two particular conditions used in measuring the expression of rrnB P1: 1) assays were indirect measurements for rRNA synthesis by following the {beta}-galactosidase activity, which is very stable, from rrnB P1-lacZ fusions; and 2) assays were from single point sampling rather than by following kinetics of cell growth.

We decided to determine the effect of fis on rRNA synthesis from the P1 promoters by following the expression of rRNA leader sequences directly as a function of cell growth (Fig. 7). Since the leader sequences of rRNAs are processed and degraded very rapidly in the cell (4951), the levels of the leader sequences of rRNAs should reflect the rate of rRNA syntheses from the P1 promoters. The kinetic study is essential because the expression of the fis gene, and thus the level of Fis inside the cell is growth phase-dependent (22). The level of Fis peaks during early log phase (30,000–60,000 dimers/cell in rich media) and is minimal in stationary phase (<=100 dimers/cell). Thus, it is likely that the effect of the fis mutation on the synthesis of rRNA will be manifested most dramatically during early log growth phase, when the Fis level peaks inside wild type cells. Following a protocol as described (22), overnight cultures were diluted 20-fold with fresh prewarmed LB, and cell growth was followed (Fig. 7A). Total RNA was isolated from both wild type and fis mutant cells at different time points during cell growth and from overnight cultures. Synthesis of rRNA was determined by primer extension method using a primer that hybridizes to a conserved region of the leader sequences initiated exclusively from the P1 promoters of four rRNA operons (rrnB, rrnA, rrnC, and rrnG). For comparison, we also determined the expression of the ompA gene in the same reactions. We chose ompA as a control, because its expression is known to be relatively abundant (52, 53), although we did not know if the expression of ompA is affected by fis.



View larger version (20K):
[in this window]
[in a new window]
 
FIG. 7.
The expression of rRNA from the P1 promoters as a function of cell growth in wild type and an isogenic fis mutant. Overnight cultures of both wild type (MG1655) strain and the MG1655 fis null mutant (DJ2592) were diluted 20-fold with prewarmed LB and grown at 37 °C. Total RNA was extracted from cell cultures at the indicated intervals and overnight cultures (0 min). Equal amounts of RNA samples (~1 µg) were used in primer extension assays as described under "Experimental Procedures." A, the growth curves of MG1655 (filled squares) and MG1655 fis (open circles) in LB at 37 °C after cell dilutions. B, an autoradiograph of a representative primer extension assay. The locations of cDNA products (119 bases for rRNA, 93 and 89 bases for ompA mRNA) are indicated. C, the relative amount of rRNA synthesized from the P1 promoters of rRNA operons, which is normalized to the level of ompA mRNA, is plotted as a function of cell growth in the MG1655 (filled circle) and MG1655 fis (open circle). The data represent an average of three independent experiments.

 
As shown in Fig. 7B, the expression of rRNAs was growth phase-dependent; in contrast, the levels of ompA transcripts were relatively constant during different growth phases (growth phase-independent) in both wild type and the fis mutant strains. Thus, the expression of rRNA (as ratios of the leader sequence transcripts over ompA transcripts) was quantified as a function of cell growth (Fig. 7C). Only a small amount of the leader sequences of rRNAs and ompA was detected in cultures grown overnight (time 0) for both strains, indicating that there was minimal transcription activity inside late stationary phase cells. However, significant amounts of the leader sequences of rRNAs were detected only 10 min after culture growth, and their expressions peaked around 30–45 min following the nutrient upshift. Afterward, the amounts of the leader sequences of rRNAs declined rapidly when cells growth slowed (60 min) and became minimal when cultures approached stationary phase (>=120 min) (Fig. 7, compare B with A).

Indeed, we found that the effect of the fis mutation on the expression of rRNAs was manifested most dramatically during the early log phase of cultures (10–45 min), parallel to the peak levels of the Fis protein in wild type cells (22). The amounts of the leader sequences of rRNAs in the fis mutant were reduced 2-fold compared with that in wild type cells. This significant difference in the amounts of the leader sequences of rRNAs between the two strains truly reflects the effect of fis on the synthesis of the transcripts, because we found that the half-life of the leader sequences of rRNAs to be the same (~55 s) in the two strains (Table I).


View this table:
[in this window]
[in a new window]
 
TABLE I
The half-life (seconds) of rRNA leader sequences in wild type and the fis mutant strains The half-lives of rRNA leader sequences in the cells grown at 37 °C were measured by primer extension as described under "Experimental Procedures." Data presented are the averages of three independent experiments.

 
Interestingly, the temporal expression profiles of rRNA in early log phase were very similar in both wild type and the fis mutant strains, indicating that element(s) other than Fis are also involved in the activation of the rrnB P1 promoters of rRNA operons. Also, the amounts of rRNA in the later growth phases appeared to be higher in the fis mutant than that in wild type cells, suggesting that the regulation of rRNA synthesis is also altered after early log phase in the fis mutant.

The above experiments suggest that the effect of the fis mutation on cell growth is manifested primarily during early log phase, since it impairs the synthesis of rRNA most significantly during this period of growth compared with wild type cells. When we followed cell growth (as a population) in LB broth (Fig. 7A), we found that the fis mutant has only a slightly slower growth rate (~10% reduction) compared with wild type cells, similar to reports by others (15, 38, 48, 54). However, when we used a more sensitive assay to monitor the rate of single cell growth by following colony formation of both wild type and the fis mutant cells on solid LB media as a function of time, we observed the expected results (Fig. 8). Indeed, after 16 h of growth at 30 °C, there was a dramatic difference in colonies size between the two strains; whereas wild type cells formed recognizable colonies, the fis mutant cells only formed tiny colonies. The differences in growth between the two strains, however, were diminished upon prolonged incubation (after 40 and 64 h of growth). Significant differences in apparent growth rates on solid media are also observed when cells are plated from log phase liquid cultures (data not shown).



View larger version (76K):
[in this window]
[in a new window]
 
FIG. 8.
The fis mutant manifests a slow growth phenotype during the initial growth phase. Overnight cultures of wild type (MG1655) strain and the MG1655 fis null mutant (DJ2592) were diluted and plated on LB plates. The plates were incubated at 30 °C and scored at the indicated time intervals.

 
To further study the effect of fis on cell growth, we took advantage of the stringent RNAP mutant rpoB3449. Because Fis had a greater effect on the transcriptional activation of rrnB P1 by the stringent RNAP compared with wild type RNAP in vitro, it is possible that the fis rpoB3449 double mutant would manifest a greater effect on cell growth than the single rpoB3449 mutant. Thus, we constructed the fis rpoB3449 double mutant and followed the growth of the double mutant and the single rpoB3449 mutant strains after 24-h stationary phase cultures were diluted into fresh LB media. For comparison, wild type and the single fis mutant strains were also included in the assays. As shown in Fig. 9, the fis rpoB3449 double mutant had the slowest growth rate with a doubling time of ~50 min, whereas the single rpoB3449 mutant had a doubling time of ~40 min. Note that the fis rpoB3449 double mutant exhibited essentially only linear growth. Whereas the wild type strain started growth at the first time point (15 min), the single fis mutant had a prolonged lag phase of about 30–45 min. However, during the log phage growth, there was only ~10% difference in growth rate between the wild type (doubling time ~22 min) and the fis mutant (doubling time ~24 min). Note that the single rpoB3449 mutant also had a prolonged lag phase, similar to the single fis mutant. It is known that the fis promoter is a stringent promoter (55, 56); thus, it is likely that the expression of fis is reduced in the stringent RNAP mutant rpoB3449. Indeed, the expression of fis in the rpoB3449 mutant was reduced both kinetically (delayed about 60 min) and quantitatively (the peak level reduced about 3-fold) when compared with wild type cells under the same conditions (data not shown). Taken together, the above results are consistent with the notion that Fis plays an important role in the establishment of a robust growth when E. coli cells are emerging from a growth-arrested state (stationary phase) to a rapid growth phase (log growth).



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 9.
Determination of cell growth of wild type and different mutant strains. Cells of different strains from stationary overnight cultures (37 °C for about 24 h) were diluted 100-fold into prewarmed LB, and growth was followed as a function of time at 37 °C.

 

    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In this study, we investigated the mechanism underlying the Fis-mediated transcriptional activation of the rrnB P1 promoter and the role of fis in rRNA synthesis as a function of cell growth in E. coli. Our results showed that Fis stabilizes the interaction between RNAP and rrnB P1, a regulatory step in transcription of the stringent promoter, thus leading to transcriptional activation of the promoter. Consistent with the in vitro data, our in vivo results demonstrate that Fis plays an important role in the establishment of robust rRNA synthesis when E. coli cells emerge from an arrested state in stationary phase to a rapid growth state in early log phase.

The Mode of Action of Fis in Transcriptional Activation of rrnB P1—Like other stringent promoters tested so far in vitro, the preinitiation complexes of rrnB P1 are intrinsically unstable because of the readily reversible nature of the steps prior to the formation of the first phosphodiester bond. Consequently, the interactions between RNAP and stringent promoters are unusually sensitive to salt concentration, DNA competitor, and superhelicity of the DNA template (4, 5, 57). The ATP concentration has been shown to be important for transcription of rrnB P1 (17, 58), probably by modulating the rate of the first phosphodiester bond (pppApC) formation. After the synthesis of pppApC, preinitiation complexes at rrnB P1 convert to an initially transcribing complex, which becomes very stable (4). This unique feature of stringent promoters (i.e. an intrinsically unstable open complex) is very likely the basis for the regulation of these genes and the stringent response. Thus, factors affecting this regulatory step of rrnB P1 would most effectively modulate the activity of the promoter. Previously, we found that the stringent RNAPs further destabilize preinitiation complexes at stringent promoters, leading to reduced RNA synthesis at rrnB P1 and other stable RNA operons (5, 9). Results from this study demonstrated that Fis also affects this regulatory step by stabilizing the preinitiation complexes at the rrnB P1 promoter, thus shifting the equilibrium toward the open complex. Our results argue that this mode of action may be largely responsible for Fis-mediated transcriptional activation of rrnB P1. In support of this model, mutational analysis of the Fis protein showed that there is a complete correlation between Fis-mediated transcription activation of rrnB P1 and Fis-mediated stabilization of preinitiation complexes of the promoter (Fig. 6), indicating that the two activities of Fis on the rrnB P1 promoter are coupled.

The fact that Fis stabilizes preinitiation complexes at rrnB P1 with both wild type and the stringent RNAPs indicates that this is a general function of Fis in transcription of the ribosomal promoter. Our results indicate that because the stringent RNAPs and the Fis protein both affect the same regulatory step in the initiation of rrnB P1, but in opposite directions, the net outcome of the transcription of the ribosomal promoter by stringent RNAPs in the presence of Fis is likely to be determined by the competing effects of the two proteins. In our study, the effects of the stringent RNAPs on destabilizing the preinitiation complexes of rrnB P1 are dominant over the effect of Fis in stabilizing the initiation complexes; thus, the mutant RNAPs are still defective in the synthesis of rrnB P1 in the presence of Fis in vitro. As expected, these stringent rpoB mutants with wild type fis still exhibit a stringent phenotype and have a very slow growth phenotype even in rich media (5, 8). Fis has also been found to almost completely compensate for the defects of other mutant RNAPs in rrnB P1 transcription in vitro (37). Consequently, those RNAP mutants with wild type fis have growth rates similar to wild type cells.

The mode of action of Fis in the initiation of rrnB P1 described in this study is consistent with some of the effects of Fis on the promoter reported previously. For example, it has been shown that Fis reduces the apparent Km for ATP, the initial nucleotide for the rrnB P1 transcript (37). It is likely that the stabilization of the open complex at rrnB P1 by Fis is responsible for the decrease in the apparent Km for ATP at the ribosomal promoter. In addition, it might explain why Fis has reduced the equilibrium dissociation constant for RNAP binding to rrnB P1 2.5-fold in DNase I footprinting assays (36). Also, it has been reported that Fis activates transcription of rrnB P1 by wild type RNAP greatly at high salt concentrations (>100 mM NaCl) but exhibits only minimal or no effect at low salt concentrations (15). This is probably due to the fact that the interaction between RNAP and the rrnB P1 promoter is relatively less stable at high salt concentrations but relatively more stable at low salt concentrations. For example, at salt concentrations of >50 mM NaCl or KCl, very few preinitiation complexes survive a challenge by heparin added at the same time as NTPs (data not shown), whereas most preinitiation complexes are stable enough to survive the heparin challenge at low salt concentration (30 mM) (Fig. 1). This also can explain why Fis exhibits greater transcriptional activation of rrnB P1 by the stringent RNAPs at low salt concentration, since those mutant RNAPs form less stable preinitiation complexes at the promoter compared with wild type RNAP (Fig. 1). Our in vitro results demonstrated that Fis exhibits a greater effect on relatively unstable open complex, indicating that Fis manifests its activity when preinitiation complexes at rrnB P1 are in a metastable state.

It is likely that Fis also stabilizes preinitiation complexes from the P1 promoters of other ribosomal operons, because common features are shared in the regulatory regions of these promoters. For example, it has been reported that Fis stabilizes initially transcribing complexes in the presence of three nucleotides at rrnD P1 (59). It is also possible that Fis behaves similarly on transcription of other stringent promoters, such as tyrT and leuV (6062), which have Fis binding sites in their regulatory regions. Further experiments will be required to determine whether this is a common mode of action by Fis on these stringent promoters.

The Role of Fis in rRNA Synthesis inside Cells—By determining the kinetic profiles of expression of the P1 promoters from several rRNA operons directly, our results demonstrated that the rRNA synthesis is reduced significantly (2-fold) in the fis mutant compared with an isogenic wild type strain when cells emerge from an arrested state in late stationary phase (overnight cultures) to a rapid growing state in early log phase (Fig. 7). The effect of fis on the synthesis of rRNA is parallel to the level of Fis inside cells, which also peaks at the first few doubling times after cell regrowth (22) and depends on growth conditions (38), indicating that Fis stimulates the robust synthesis of rRNA during the transition in growth phases. It is known that stability of preinitiation complexes of stringent promoters are enhanced significantly by supercoiled DNA (5, 57). Moreover, it has been shown that DNA is relatively more relaxed in overnight cultures than in rapidly growing cultures (64, 65). Thus, it is likely that the interactions between RNAP and the rRNA promoters are less stable in stationary phase cells compared with those in rapid growing cells, providing a basis for the modulation by Fis at the transition in cellular growth states. The potential role of Fis in transcription of rRNA during the transition from stationary phase to early log phase has been proposed (15, 62) and challenged (37, 66). Also, it has been reported that Fis activates transcription of rrnB P1 throughout exponential growth at low culture density (66). Other models on the role of Fis in the rRNA synthesis have also been suggested (60, 67). It is interesting to note that the expression of wild type rrnB P1 promoter is 2-fold higher than that of a mutant rrnB P1 promoter that lacks the Fis binding site (66). Our study demonstrates that Fis plays an important role in establishing robust rRNA synthesis when cells emerge from an arrested state into a rapid growing state. Consistent with the effect of fis on the rRNA synthesis, our results showed that Fis plays a critical role in the establishment of robust growth of E. coli when cells are outgrowing from an arrested state (long term stationary phase) to a rapid growth state (log phage), primarily by reducing the lag time (Figs. 8 and 9).

It should be noted that although the expression of rRNA is reduced in the fis mutant during the early log growth compared with wild type strain, the overall shapes of expression profiles are parallel in the two strains. This indicates that element(s) other than Fis are also involved in the up-regulation of the P1 promoters of several rRNA operons during the early log growth phase. Major candidates are the ATP/GTP concentration, which play an important role in the synthesis of rRNA in vivo and in vitro (17, 58) and (p)ppGpp, which is known to be at its lowest concentration in rapidly growing cells (68). In addition, other nucleoid-associated proteins such as H-NS, StpA, and HU, as well as DNA gyrase, directly or indirectly contribute to the control of rrn P1 activity (19, 63, 69, 70). Clearly, regulation of the ribosomal promoters is multivalent. Modulation of the transcription activity of the P1 promoters of rRNA by Fis in early log growing cells is an integral element in the control of cell growth.


    FOOTNOTES
 
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} These two authors contributed equally to this work. Back

§ Present address: Dept. of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294. Back

|| To whom correspondence should be addressed: Laboratory of Molecular Biology, NCI, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892. Tel.: 301-402-9281; E-mail: djjin{at}helix.nih.gov.

1 The abbreviation used is: RNAP, RNA polymerase. Back



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Ingraham, J. L., Maalfe, O., and Neidhardt, F. C. (1983) Growth of the Bacterial Cell, Sinauer, Sundeerland, MA
  2. Nomura, M., Gourse, R., and Baughman, G. (1984) Annu. Rev. Biochem. 53, 75-117[CrossRef][Medline] [Order article via Infotrieve]
  3. Cashel, M., Gentry, D. R., Hernandez, V. J., and Vinella, D. (1996) in Escherichia coli and Salmonella typhimurium (Neidhardt, F. C., ed) pp. 1458-1496, American Society for Microbiology Press, Washington, D. C.
  4. Gourse, R. L. (1988) Nucleic Acids Res. 16, 9789-9809[Abstract/Free Full Text]
  5. Zhou, Y. N., and Jin, D. J. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2908-2913[Abstract/Free Full Text]
  6. McClure, W. R. (1980) Proc. Natl. Acad. Sci. U. S. A. 77, 5634-5638[Abstract/Free Full Text]
  7. Jin, D. J., and Gross, C. A. (1988) J. Mol. Biol. 202, 45-58[CrossRef][Medline] [Order article via Infotrieve]
  8. Jin, D. J., and Gross, C. A. (1989) J. Bacteriol. 171, 5229-5231[Abstract/Free Full Text]
  9. Zhou, Y. N., and Jin, D. J. (1997) J. Bacteriol. 179, 4292-4298[Abstract/Free Full Text]
  10. Bartlett, M. S., Gaal, T., Ross, W., and Gourse, R. L. (1998) J. Mol. Biol. 279, 331-345[CrossRef][Medline] [Order article via Infotrieve]
  11. Gourse, R. L., Gaal, T., Bartlett, M. S., Appleman, J. A., and Ross, W. (1996) Annu. Rev. Microbiol. 50, 645-677[CrossRef][Medline] [Order article via Infotrieve]
  12. Condon, C., Philips, J., Fu, Z. Y., Squires, C., and Squires, C. L. (1992) EMBO J. 11, 4175-4185[Medline] [Order article via Infotrieve]
  13. Gourse, R. L., de Boer, H. A., and Nomura, M. (1986) Cell 44, 197-205[CrossRef][Medline] [Order article via Infotrieve]
  14. Ross, W., Gosink, K. K., Salomon, J., Igarashi, K., Zou, C., Ishihama, A., Severinov, K., and Gourse, R. L. (1993) Science 262, 1407-1413[Abstract/Free Full Text]
  15. Ross, W., Thompson, J. F., Newlands, J. T., and Gourse, R. L. (1990) EMBO J. 9, 3733-3742[Medline] [Order article via Infotrieve]
  16. Schroder, O., and Wagner, R. (2000) J. Mol. Biol. 298, 737-748[CrossRef][Medline] [Order article via Infotrieve]
  17. Gaal, T., Bartlett, M. S., Ross, W., Turnbough, C. L., Jr., and Gourse, R. L. (1997) Science 278, 2092-2097[Abstract/Free Full Text]
  18. Tippner, D., Afflerbach, H., Bradaczek, C., and Wagner, R. (1994) Mol. Microbiol. 11, 589-604[CrossRef][Medline] [Order article via Infotrieve]
  19. Johansson, J., Balsalobre, C., Wang, S. Y., Urbonaviciene, J., Jin, D. J., Sonden, B., and Uhlin, B. E. (2000) Cell 102, 475-485[CrossRef][Medline] [Order article via Infotrieve]
  20. Finkel, S. E., and Johnson, R. C. (1992) Mol. Microbiol. 6, 3257-3265[Medline] [Order article via Infotrieve]
  21. McLeod, S. M., and Johnson, R. C. (2001) Curr. Opin. Microbiol. 4, 152-159[CrossRef][Medline] [Order article via Infotrieve]
  22. Ball, C. A., Osuna, R., Ferguson, K. C., and Johnson, R. C. (1992) J. Bacteriol. 174, 8043-8056[Abstract/Free Full Text]
  23. Ali Azam, T., Iwata, A., Nishimura, A., Ueda, S., and Ishihama, A. (1999) J. Bacteriol. 181, 6361-6370[Abstract/Free Full Text]
  24. Kostrewa, D., Granzin, J., Koch, C., Choe, H. W., Raghunathan, S., Wolf, W., Labahn, J., Kahmann, R., and Saenger, W. (1991) Nature 349, 178-180[CrossRef][Medline] [Order article via Infotrieve]
  25. Yuan, H. S., Finkel, S. E., Feng, J. A., Kaczor-Grzeskowiak, M., Johnson, R. C., and Dickerson, R. E. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9558-9562[Abstract/Free Full Text]
  26. Safo, M. K., Yang, W. Z., Corselli, L., Cramton, S. E., Yuan, H. S., and Johnson, R. C. (1997) EMBO J. 16, 6860-6873[CrossRef][Medline] [Order article via Infotrieve]
  27. Osuna, R., Finkel, S. E., and Johnson, R. C. (1991) EMBO J. 10, 1593-1603[Medline] [Order article via Infotrieve]
  28. Koch, C., Ninnemann, O., Fuss, H., and Kahmann, R. (1991) Nucleic Acids Res. 19, 5915-5922[Abstract/Free Full Text]
  29. Gosink, K. K., Gaal, T., Bokal, A. J., and Gourse, R. L. (1996) J. Bacteriol. 178, 5182-5187[Abstract/Free Full Text]
  30. Bokal, A. J., Ross, W., Gaal, T., Johnson, R. C., and Gourse, R. L. (1997) EMBO J. 16, 154-162[CrossRef][Medline] [Order article via Infotrieve]
  31. Cheng, Y. S., Yang, W. Z., Johnson, R. C., and Yuan, H. S. (2000) J. Mol. Biol. 302, 1139-1151[CrossRef][Medline] [Order article via Infotrieve]
  32. McLeod, S. M., Xu, J., Cramton, S. E., Gaal, T., Gourse, R. L., and Johnson, R. C. (1999) J. Mol. Biol. 294, 333-346[CrossRef][Medline] [Order article via Infotrieve]
  33. Aiyar, S. E., McLeod, S. M., Ross, W., Hirvonen, C. A., Thomas, M. S., Johnson, R. C., and Gourse, R. L. (2002) J. Mol. Biol. 316, 501-516[CrossRef][Medline] [Order article via Infotrieve]
  34. Rochman, M., Aviv, M., Glaser, G., and Muskhelishvili, G. (2002) EMBO Rep. 3, 355-360[Medline] [Order article via Infotrieve]
  35. Hirvonen, C. A., Ross, W., Wozniak, C. E., Marasco, E., Anthony, J. R., Aiyar, S. E., Newburn, V. H., and Gourse, R. L. (2001) J. Bacteriol. 183, 6305-6314[Abstract/Free Full Text]
  36. Bokal, A. J., Ross, W., and Gourse, R. L. (1995) J. Mol. Biol. 245, 197-207[CrossRef][Medline] [Order article via Infotrieve]
  37. Bartlett, M. S., Gaal, T., Ross, W., and Gourse, R. L. (2000) J. Bacteriol. 182, 1969-1977[Abstract/Free Full Text]
  38. Nilsson, L., Verbeek, H., Vijgenboom, E., van Drunen, C., Vanet, A., and Bosch, L. (1992) J. Bacteriol. 174, 921-929[Abstract/Free Full Text]
  39. Hager, D. A., Jin, D. J., and Burgess, R. R. (1990) Biochemistry 29, 7890-7894[CrossRef][Medline] [Order article via Infotrieve]
  40. Miller, J. H. (1972) Experiments in Molecular Genetics, Cold Spring Harbor Laboratory Press, Plainview, NY
  41. Hraiky, C., Raymond, M. A., and Drolet, M. (2000) J. Biol. Chem. 275, 11257-11263[Abstract/Free Full Text]
  42. Pfeffer, S. R., Stahl, S. J., and Chamberlin, M. J. (1977) J. Biol. Chem. 252, 5403-5407[Abstract/Free Full Text]
  43. Cayley, S., Lewis, B. A., Guttman, H. J., and Record, M. T., Jr. (1991) J. Mol. Biol. 222, 281-300[CrossRef][Medline] [Order article via Infotrieve]
  44. Travers, A. A. (1980) J. Bacteriol. 141, 973-976[Abstract/Free Full Text]
  45. Pemberton, I. K., Muskhelishvili, G., Travers, A. A., and Buckle, M. (2000) J. Mol. Biol. 299, 859-864[CrossRef][Medline] [Order article via Infotrieve]
  46. Barker, M. M., Gaal, T., Josaitis, C. A., and Gourse, R. L. (2001) J. Mol. Biol. 305, 673-688[CrossRef][Medline] [Order article via Infotrieve]
  47. Cabrera, J. E., and Jin, D. J. (2001) J. Bacteriol. 183, 6126-6134[Abstract/Free Full Text]
  48. Zhang, X., and Bremer, H. (1996) J. Mol. Biol. 259, 27-40[CrossRef][Medline] [Order article via Infotrieve]
  49. Srivastava, A. K., and Schlessinger, D. (1990) Annu. Rev. Microbiol. 44, 105-129[CrossRef][Medline] [Order article via Infotrieve]
  50. Sarmientos, P., Sylvester, J. E., Contente, S., and Cashel, M. (1983) Cell 32, 1337-1346[CrossRef][Medline] [Order article via Infotrieve]
  51. Goldenberg, D., Azar, I., and Oppenheim, A. B. (1996) Mol. Microbiol. 19, 241-248[CrossRef][Medline] [Order article via Infotrieve]
  52. Wei, Y., Lee, J. M., Richmond, C., Blattner, F. R., Rafalski, J. A., and LaRossa, R. A. (2001) J. Bacteriol. 183, 545-556[Abstract/Free Full Text]
  53. Cole, S. T., Bremer, E., Hindennach, I., and Henning, U. (1982) Mol. Gen. Genet. 188, 472-479[CrossRef][Medline] [Order article via Infotrieve]
  54. Osuna, R., Lienau, D., Hughes, K. T., and Johnson, R. C. (1995) J. Bacteriol. 177, 2021-2032[Abstract/Free Full Text]
  55. Ninnemann, O., Koch, C., and Kahmann, R. (1992) EMBO J. 11, 1075-1083[Medline] [Order article via Infotrieve]
  56. Walker, K. A., Atkins, C. L., and Osuna, R. (1999) J. Bacteriol. 181, 1269-1280[Abstract/Free Full Text]
  57. Leirmo, S., and Gourse, R. L. (1991) J. Mol. Biol. 220, 555-568[CrossRef][Medline] [Order article via Infotrieve]
  58. Schneider, D. A., Gaal, T., and Gourse, R. L. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 8602-8607[Abstract/Free Full Text]
  59. Sander, P., Langert, W., and Mueller, K. (1993) J. Biol. Chem. 268, 16907-16916[Abstract/Free Full Text]
  60. Muskhelishvili, G., Buckle, M., Heumann, H., Kahmann, R., and Travers, A. A. (1997) EMBO J. 16, 3655-3665[CrossRef][Medline] [Order article via Infotrieve]
  61. Ross, W., Salomon, J., Holmes, W. M., and Gourse, R. L. (1999) J. Bacteriol. 181, 3864-3868[Abstract/Free Full Text]
  62. Nilsson, L., Vanet, A., Vijgenboom, E., and Bosch, L. (1990) EMBO J. 9, 727-734[Medline] [Order article via Infotrieve]
  63. Dame, R. T., Wyman, C., Wurm, R., Wagner, R., and Goosen, N. (2002) J. Biol. Chem. 277, 2146-2150[Abstract/Free Full Text]
  64. Balke, V. L., and Gralla, J. D. (1987) J. Bacteriol. 169, 4499-4506[Abstract/Free Full Text]
  65. Bordes, P., Conter, A., Morales, V., Bouvier, J., Kolb, A., and Gutierrez, C. (2003) Mol. Microbiol. 48, 561-571[CrossRef][Medline] [Order article via Infotrieve]
  66. Appleman, J. A., Ross, W., Salomon, J., and Gourse, R. L. (1998) J. Bacteriol. 180, 1525-1532[Abstract/Free Full Text]
  67. Schneider, R., Travers, A., Kutateladze, T., and Muskhelishvili, G. (1999) Mol. Microbiol. 34, 953-964[CrossRef][Medline] [Order article via Infotrieve]
  68. Ryals, J., Little, R., and Bremer, H. (1982) J. Bacteriol. 151, 1261-1268[Abstract/Free Full Text]
  69. Travers, A., Schneider, R., and Muskhelishvili, G. (2001) Biochimie 83, 213-217[Medline] [Order article via Infotrieve]
  70. Muskhelishvili, G., and Travers, A. (2003) Front. Biosci. 8, 279-285

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Genome ResHome page
B.-K. Cho, E. M. Knight, C. L. Barrett, and B. O. Palsson
Genome-wide analysis of Fis binding in Escherichia coli indicates a causative role for A-/AT-tracts
Genome Res., June 1, 2008; 18(6): 900 - 910.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
T. Durfee, A.-M. Hansen, H. Zhi, F. R. Blattner, and D. J. Jin
Transcription Profiling of the Stringent Response in Escherichia coli
J. Bacteriol., February 1, 2008; 190(3): 1084 - 1096.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
M. D. Bradley, M. B. Beach, A. P. J. de Koning, T. S. Pratt, and R. Osuna
Effects of Fis on Escherichia coli gene expression during different growth stages
Microbiology, September 1, 2007; 153(9): 2922 - 2940.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Chakraborty and V. Nagaraja
Dual Role for Transactivator Protein C in Activation of mom Promoter of Bacteriophage Mu
J. Biol. Chem., March 31, 2006; 281(13): 8511 - 8517.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Liu, T. Durfee, J. E. Cabrera, K. Zhao, D. J. Jin, and F. R. Blattner
Global Transcriptional Programs Reveal a Carbon Source Foraging Strategy by Escherichia coli
J. Biol. Chem., April 22, 2005; 280(16): 15921 - 15927.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
M. Hirsch and T. Elliott
Fis Regulates Transcriptional Induction of RpoS in Salmonella enterica
J. Bacteriol., March 1, 2005; 187(5): 1568 - 1580.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/47/47340    most recent
M305430200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhi, H.
Right arrow Articles by Jin, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhi, H.
Right arrow Articles by Jin, D. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement